A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validation - Takeaways - MDSpire

A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validation

  • By

  • Hamza A. Salim

  • Sarimar Agosto

  • Heba Al Qudah

  • Kim Learned

  • Mark Zafereo

  • Jennifer Wang

  • Mimi I. Hu

  • Ahmed Msherghi

  • Naifa Busaidy

  • F. Eymen Ucisik

  • Sarah Hamidi

  • Hussein Tawbi

  • Rami W. Eldaya

  • Jing Li

  • Max Wintermark

  • Maria E. Cabanillas

  • April 14, 2026

  • 0 min

Share

  • 1

    Differentiated thyroid carcinoma (DTC) has a low incidence of brain metastases, affecting 0.1–1.3% of patients, but significantly worsens prognosis.

  • 2

    A novel prognostic scoring system, the Differentiated Thyroid Cancer GPA (DTC-GPA), was developed to aid in risk stratification for patients with DTC-related brain metastases.

  • 3

    The study analyzed data from 10,306 DTC patients to identify key prognostic factors influencing overall survival after brain metastasis diagnosis.

  • 4

    Current prognostic models for brain metastases are not specific to thyroid cancer, highlighting the need for tailored approaches in clinical decision-making.

  • 5

    The DTC-GPA aims to standardize survival predictions and treatment strategies for patients with brain metastases from differentiated thyroid carcinoma.

Original Source(s)

A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validation

  • by Hamza A. Salim, Sarimar Agosto, Heba Al Qudah, Kim Learned, Mark Zafereo, Jennifer Wang, Mimi I. Hu, Ahmed Msherghi, Naifa Busaidy, F. Eymen Ucisik, Sarah Hamidi, Hussein Tawbi, Rami W. Eldaya, Jing Li, Max Wintermark, Maria E. Cabanillas

  • April 14, 2026

Related Content

Neurobehavioral outcomes and associated risk factors in pediatric brain tumor survivors

Dana-Farber Research News 03.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from February 16 - 28.

  • by

  • March 15, 2026

  • 21 min
Dana Farber/Boston Children’s Researchers Uncover Distinct Tumor “neighborhoods” with Each Cell Subtype Playing a Specific Role, in Aggressive Childhood Brain Cancer

Their detailed blueprint of tumor cell diversity could guide more precise, targeted treatments for supratentorial ependymomas 

  • by

  • March 12, 2026

  • 3 min